Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory G Burrows

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|October 1, 2009
Recombinant TCR ligand reverses clinical signs and CNS damage of EAE induced by recombinant human MOGSushmita Sinha, Sandhya Subramanian, Ashley Emerson-Webber, et al.
Journal of Neuroimmunology|June 16, 2010
Binding of recombinant T cell receptor ligands (RTL) to antigen presenting cells prevents upregulation of CD11b and inhibits T cell activation and transfer of experimental autoimmune encephalomyelitisSushmita Sinha, Lisa Miller, Sandhya Subramanian, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 2014
HLA-DRα1 constructs block CD74 expression and MIF effects in experimental autoimmune encephalomyelitisRoberto Meza-Romero, Gil Benedek, Xiaolin Yu, et al.
Journal of Neuroinflammation|November 10, 2010
Characterization of human platelet binding of recombinant T cell receptor ligandAsako Itakura, Joseph E Aslan, Sushmita Sinha, et al.
Stem Cells Translational Medicine|August 29, 2013
Dissection of the human multipotent adult progenitor cell secretome by proteomic analysisGregory G Burrows, Wouter Van't Hof, Laura F Newell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 5, 2006
Recombinant HLA-DP2 binds beryllium and tolerizes beryllium-specific pathogenic CD4+ T cellsAndrew P Fontenot, Timothy S Keizer, Mark McCleskey, et al.
Journal of Autoimmunity|October 3, 2012
A novel regulatory pathway for autoimmune disease: binding of partial MHC class II constructs to monocytes reduces CD74 expression and induces both specific and bystander T-cell toleranceArthur A Vandenbark, Roberto Meza-Romero, Gil Benedek, et al.
Journal of Chemical Technology and Biotechnology (Oxford, Oxfordshire : 1986)|September 14, 2012
Rationally designed mutations convert complexes of human recombinant T cell receptor ligands into monomers that retain biological activityJianya Y Huan, Roberto Meza-Romero, Jeffery L Mooney, et al.
Stem Cells Translational Medicine|October 24, 2015
Solution-Phase Crosstalk and Regulatory Interactions Between Multipotent Adult Progenitor Cells and Peripheral Blood Mononuclear CellsGregory G Burrows, Wouter Van't Hof, Ashok P Reddy, et al.
Journal of Neuroscience Research|September 8, 2004
T-cell hybridoma specific for myelin oligodendrocyte glycoprotein-35-55 peptide produced from HLA-DRB1*1501-transgenic miceYuan K Chou, Nicole Culbertson, Cathleen Rich, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|October 1, 2009
Recombinant TCR ligand reverses clinical signs and CNS damage of EAE induced by recombinant human MOGSushmita Sinha, Sandhya Subramanian, Ashley Emerson-Webber, et al.
Journal of Neuroimmunology|June 16, 2010
Binding of recombinant T cell receptor ligands (RTL) to antigen presenting cells prevents upregulation of CD11b and inhibits T cell activation and transfer of experimental autoimmune encephalomyelitisSushmita Sinha, Lisa Miller, Sandhya Subramanian, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 2014
HLA-DRα1 constructs block CD74 expression and MIF effects in experimental autoimmune encephalomyelitisRoberto Meza-Romero, Gil Benedek, Xiaolin Yu, et al.
Journal of Neuroinflammation|November 10, 2010
Characterization of human platelet binding of recombinant T cell receptor ligandAsako Itakura, Joseph E Aslan, Sushmita Sinha, et al.
Stem Cells Translational Medicine|August 29, 2013
Dissection of the human multipotent adult progenitor cell secretome by proteomic analysisGregory G Burrows, Wouter Van't Hof, Laura F Newell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 5, 2006
Recombinant HLA-DP2 binds beryllium and tolerizes beryllium-specific pathogenic CD4+ T cellsAndrew P Fontenot, Timothy S Keizer, Mark McCleskey, et al.
Journal of Autoimmunity|October 3, 2012
A novel regulatory pathway for autoimmune disease: binding of partial MHC class II constructs to monocytes reduces CD74 expression and induces both specific and bystander T-cell toleranceArthur A Vandenbark, Roberto Meza-Romero, Gil Benedek, et al.
Journal of Chemical Technology and Biotechnology (Oxford, Oxfordshire : 1986)|September 14, 2012
Rationally designed mutations convert complexes of human recombinant T cell receptor ligands into monomers that retain biological activityJianya Y Huan, Roberto Meza-Romero, Jeffery L Mooney, et al.
Stem Cells Translational Medicine|October 24, 2015
Solution-Phase Crosstalk and Regulatory Interactions Between Multipotent Adult Progenitor Cells and Peripheral Blood Mononuclear CellsGregory G Burrows, Wouter Van't Hof, Ashok P Reddy, et al.
Journal of Neuroscience Research|September 8, 2004
T-cell hybridoma specific for myelin oligodendrocyte glycoprotein-35-55 peptide produced from HLA-DRB1*1501-transgenic miceYuan K Chou, Nicole Culbertson, Cathleen Rich, et al.
Pageof 5